Page last updated: 2024-11-02

phenindione and Chemotherapy-Induced Febrile Neutropenia

phenindione has been researched along with Chemotherapy-Induced Febrile Neutropenia in 1 studies

Phenindione: An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234)

Chemotherapy-Induced Febrile Neutropenia: FEVER accompanied by a significant reduction in NEUTROPHIL count associated with CHEMOTHERAPY.

Research Excerpts

ExcerptRelevanceReference
"This rare side effect is a reminder of the importance of biological monitoring in the first weeks following the introduction of fluindione and key diagnostic elements and therapeutic aspects of iatrogenic agranulocytosis."7.83[Agranulocytosis related to fluindione: A case report]. ( Armengol, G; Benhamou, Y; Buchonnet, G; Cailleux-Talbot, N; Lévesque, H; Massy, N; Ngo, S; Sauvêtre, G, 2016)
"This rare side effect is a reminder of the importance of biological monitoring in the first weeks following the introduction of fluindione and key diagnostic elements and therapeutic aspects of iatrogenic agranulocytosis."3.83[Agranulocytosis related to fluindione: A case report]. ( Armengol, G; Benhamou, Y; Buchonnet, G; Cailleux-Talbot, N; Lévesque, H; Massy, N; Ngo, S; Sauvêtre, G, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ngo, S1
Benhamou, Y1
Armengol, G1
Sauvêtre, G1
Cailleux-Talbot, N1
Massy, N1
Buchonnet, G1
Lévesque, H1

Other Studies

1 other study available for phenindione and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
[Agranulocytosis related to fluindione: A case report].
    La Revue de medecine interne, 2016, Volume: 37, Issue:1

    Topics: Aged; Agranulocytosis; Anticoagulants; Chemotherapy-Induced Febrile Neutropenia; Drug Hypersensitivi

2016